Yehuda Shoenfeld

This inventor holds 12 USPTO granted patents and 3 EPO patents. Top assignees: Tpcera Ltd., Omrix Biopharmaceuticals Inc., Yeda Research and Develpment & Co. Ltd. Active years: 2004-2025.

USPTO Granted Patents = 12

% Patents Active = 75.0

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 25(Granted Patents)

Company Filing History:

Omrix Biopharmaceuticals Inc.

patents

2 out of 1,168

Yeda Research and Develpment & Co. Ltd

patents

4. 1 out of 131

Tel Hashomer Medical Research Infrastructure and Services Ltd.

patents

Years Active: 2004-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12350308 - Phosphorylcholine conjugates and uses thereof (2025-07-08),

2. 11696935 - Phosphorylcholine conjugates and uses thereof (2023-07-11),

3. 11458186 - Phosphorylcholine conjugates and uses thereof (2022-10-04),

4. 10881707 - Phosphorylcholine conjugates and uses thereof (2021-01-05),

5. 10842844 - Phosphorylcholine conjugates and uses thereof (2020-11-24),

6. 10046021 - Phosphorylcholine conjugates and uses thereof (2018-08-14),

7. 10040869 - Molecules mimicking an autoantibody idiotype and compositions containing same (2018-08-07),

8. 9987372 - Phosphorylcholine conjugates and uses thereof (2018-06-05),

9. 9975944 - Synthetic peptides for the treatment of autoimmune diseases (2018-05-22),

10. 8450067 - Method for obtaining anti-idiotype antibodies (2013-05-28),

11. 7053178 - Synthetic peptides and kits for diagnosis of anti-phospholipid syndrome (2006-05-30),

12. 6825319 - Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome (2004-11-30),

Title: Yehuda Shoenfeld: A Pioneer in Autoimmune Disease Research

Introduction

Yehuda Shoenfeld is a distinguished inventor and researcher based in Ramat-Gan, Israel. With an impressive portfolio of 11 patents, he has made significant contributions to the field of autoimmune disease treatment. His work focuses on innovative therapies that aim to improve the lives of those afflicted by these complex disorders.

Latest Patents

Among his latest patents is a groundbreaking invention related to phosphorylcholine conjugates. This invention provides complex pharmaceutical compositions designed for the prevention or treatment of autoimmune diseases. Specifically, the conjugates developed by Shoenfeld demonstrate effectiveness in treating autoimmune diseases associated with pathological inflammation, thus offering new hope for patients battling these conditions.

Career Highlights

Throughout his career, Yehuda Shoenfeld has collaborated with notable organizations, including Tpcera Ltd. and Yeda Research and Development Company. His work at these companies has allowed him to explore innovative treatment avenues and contribute to advancements in medical science.

Collaborations

Shoenfeld’s collaborations with fellow researchers have been instrumental in his success. Notable colleagues include Miriam Blank and Miri Blank, who have worked alongside him in various capacities to propel research efforts and patent developments in autoimmune therapies.

Conclusion

In summary, Yehuda Shoenfeld stands as a prominent figure in the field of autoimmune disease research and innovation. Through his numerous patents and collaborative efforts, he continues to pave the way for new therapeutic strategies that hold the potential to transform the landscape of treatment for autoimmune diseases. As research in this area progresses, his contributions will undoubtedly leave a lasting impact on medical science.